Amedisys, Inc. (NASDAQ:AMED) Short Interest Update

Amedisys, Inc. (NASDAQ:AMED) was the target of a significant growth in short interest in the month of November. As of November 30th, there was short interest totalling 2,590,000 shares, a growth of 18.8% from the November 15th total of 2,180,000 shares. Based on an average daily volume of 488,500 shares, the short-interest ratio is currently 5.3 days. Currently, 8.1% of the company’s shares are sold short.

Amedisys Trading Up 0.1 %

AMED traded up $0.08 during trading on Friday, hitting $85.68. The company’s stock had a trading volume of 388,021 shares, compared to its average volume of 372,868. The firm has a market capitalization of $2.81 billion, a P/E ratio of 34.00, a PEG ratio of 1.84 and a beta of 0.73. Amedisys has a twelve month low of $84.06 and a twelve month high of $98.95. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. The stock’s fifty day moving average price is $92.66 and its 200-day moving average price is $94.94.

Amedisys (NASDAQ:AMED) last posted its earnings results on Wednesday, November 6th. The health services provider reported $1.00 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.19). The firm had revenue of $587.67 million for the quarter, compared to the consensus estimate of $586.75 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. Amedisys’s quarterly revenue was up 5.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.98 EPS. Analysts anticipate that Amedisys will post 4.45 EPS for the current year.

Institutional Investors Weigh In On Amedisys

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in AMED. KBC Group NV bought a new position in shares of Amedisys during the third quarter valued at $63,000. Innealta Capital LLC bought a new stake in Amedisys in the second quarter worth $64,000. Signaturefd LLC raised its position in Amedisys by 88.2% in the 2nd quarter. Signaturefd LLC now owns 1,131 shares of the health services provider’s stock worth $104,000 after purchasing an additional 530 shares during the period. CWM LLC boosted its position in shares of Amedisys by 14.5% during the third quarter. CWM LLC now owns 2,190 shares of the health services provider’s stock valued at $211,000 after buying an additional 277 shares during the period. Finally, Crossmark Global Holdings Inc. purchased a new stake in shares of Amedisys in the third quarter worth approximately $243,000. 94.36% of the stock is currently owned by institutional investors.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.